logo

Shariah compliance overview

Halal

Phathom Pharmaceuticals, Inc. (PHAT) is currently classified as Halal by Akinda Shariah screening (AAOIFI-aligned methodology).

About Phathom Pharmaceuticals, Inc.

Phathom Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm, dedicated to advancing and commercializing therapies for gastrointestinal ailments.

Phathom Pharmaceuticals, Inc. (PHAT) operates in the Healthcare sector, in the Biotechnology industry.

Why it is halal: it passes all three AAOIFI screens. Non-compliant revenue is 3.87% (limit 5%), interest-bearing debt is 27.29% (limit 30%) and interest-bearing securities and assets are 16.96% (limit 30%).

If you hold PHAT, give 3.87% of the dividends you receive to charity to purify the non-compliant share of its income.

Business Activity
3.87%Limit 5%Pass
Interest-bearing debt
27.29%Limit 30%Pass
Interest-bearing securities and assets
16.96%Limit 30%Pass
Dividend purification
3.87%Share of dividends to give to charityPurification calculator

Last updated: Nov 3, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.

Please login to access this content

Key stats

Please login to access this content

Please login to access this content

Company Profile

Please login to access this content

Frequently asked questions

Quick answers about Phathom Pharmaceuticals, Inc. (PHAT). Current Akinda screening label: Halal.